Valiant Organics Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 investor presentation: what the company reported on revenue, margins and capex.
- Revenue
- ₹157Cr
- −1.9% YoY
- −23% QoQ
- Net profit
- ₹6Cr
- Turned profitable YoY
- −25% QoQ
- Margin
- 13%
- +12.5 pp YoY
- +1 pp QoQ
Top 10 Chemicals & Petrochemicals companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on Valiant Organics Ltd's Q2 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2-FY26 consolidated revenue from operations: INR 1,573 million, down 1.8% year-on-year (Page 12). Q2-FY26 Consolidated Financial Highlights: - EBITDA: INR 212 Mn (up from INR 24 Mn in Q2-FY25) - Operating EBITDA Margin: 13.48% (up from 1.50% in Q2-FY25) - PAT: INR 57 Mn (compared to a loss of INR 125 Mn in Q2-FY25) - PAT Margin: 3.62% (compared to -7.80% in Q2-FY25) - Year-on-year change shows a significant turnaround in profitability and margin expansion.
From Valiant Organics Ltd's Q2 FY26 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Q2-FY26 consolidated revenue from operations: INR 1,573 million, down 1.8% year-on-year (Page 12).
- Q2-FY26 standalone revenue from operations: INR 1,572 million, down 1.9% year-on-year (Page 14).
- Q2-FY26 sales volumes by chemistry (MT):
- Chlorination: 274 MT (Page 11)
- Hydrogenation: 394 MT
- Ammonolysis: 286 MT
2 more points from Valiant Organics Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Valiant Organics Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
See what Valiant Organics Ltd said on capital expenditure plans — free account, 30 seconds.
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Valiant Organics Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Valiant Organics Ltd said on order book & pipeline — free account, 30 seconds.
Valiant Organics Ltd — Quarterly revenue & net profit
Valiant Organics Ltd Q2 FY26 results — key figures
| ₹ Cr | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 157 | 160 | -1.9% | 204 | -23% |
| Operating profit (EBITDA) | 21 | 1 | +2000% | 25 | -16% |
| Operating margin | 13% | 0.5% | +12.5 pp | 12% | +1 pp |
| Profit before tax | 7 | -14 | — | 11 | -36.4% |
| Net profit (PAT) | 6 | -12 | — | 8 | -25% |
| EPS (₹) | 2.02 | -4.63 | — | 2.93 | -31.1% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹304 Cr, net profit ₹17 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Valiant Organics's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Gujarat Alkalies (Q2 FY26)
2,136.64 Crores (Page 21). Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q2 FY26 investor presentation — and how it ranks against
- Dynemic Products (Q2 FY26)
Quarterly revenue for Q2 FY 25-26: ₹8,935 lakhs (Page 12, 10, 5) . Key investor presentation takeaways from Dynemic Products's Q2 FY26 investor presentation — a
- Platinum Industr (Q2 FY26)
Q2FY26 Revenue from Operations (Consolidated): INR 983.8 Mn, down 1% YoY from INR 996.4 Mn in Q2FY25. Key investor presentation takeaways from Platinum Industri
- IVP (Q2 FY26)
Revenue from Operations for Q2FY26: ₹146.95 crores . Key investor presentation takeaways from IVP's Q2 FY26 investor presentation — and how it ranks against sec
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Valiant Organics Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Valiant Organics Ltd Q2 FY26 results?
Q2-FY26 consolidated revenue from operations: INR 1,573 million, down 1.8% year-on-year (Page 12). Q2-FY26 Consolidated Financial Highlights: - EBITDA: INR 212 Mn (up from INR 24 Mn in Q2-FY25) - Operating EBITDA Margin: 13.48% (up from 1.50% in Q2-FY25) - PAT: INR 57 Mn (compared to a loss of INR 125 Mn in Q2-FY25) - PAT Margin: 3.62% (compared to -7.80% in Q2-FY25) - Year-on-year change shows a significant turnaround in profitability and margin expansion.
What is Valiant Organics Ltd share price analysis?
Valiant Organics Ltd currently shows a neutral. The stock trades at a P/E of 23.7 with a market cap of ₹1,196 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Valiant Organics Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
